The International Generic and Biosimilar Medicines Association (IGBA) announced today that it has appointed a Chair and Vice-Chair for its newly established Committee. Richard Saynor, CEO Sandoz, has been nominated as inaugural Chair, and Vinita Gupta, CEO Lupin, has been appointed Vice-Chair, both effective January 1, 2023, for a term of one year.
